Overview

The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis

Status:
Terminated

Trial end date:
2021-05-17

Target enrollment:

Participant gender:

Summary

Pregnant women with a history of opioid use disorder, chronic opioid use or those who are on medication assisted treatment will be randomly assigned to receive either a sub-fascial continuous infusion of bupivacaine or lidocaine/menthol patch after Cesarean delivery. Post-operative pain scores and opioid usage in the post-operative period will be recorded.

Phase:

Phase 4

Details

Lead Sponsor:

WellSpan Health

Collaborators:

Ambu A/S
York Opioid Collaborative
York Opioid Collaborative, Pennsylvania

Treatments:

Analgesics
Bupivacaine
Lidocaine
Menthol